(Q43845419)

reason for preferred rank

27 November 2017

title

Mismatched double-stranded RNA, ampligen (poly(I) : poly(C12U)), demonstrates antiviral and immunostimulatory activities in HIV disease (English)

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90127-S

29 October 2022

Mismatched double-stranded RNA, Ampligen (poly(I): poly(C12U), demonstrates antiviral and immunostimulatory activities in HIV disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1688087

29 October 2022

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90127-S

29 October 2022

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90127-S

29 October 2022

author name string

W. A. Carter

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1688087

29 October 2022

D. Ventura

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1688087

29 October 2022

D. E. Shapiro

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1688087

29 October 2022

D. R. Strayer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1688087

29 October 2022

D. H. Gillespie

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1688087

29 October 2022

H. R. Hubbell

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1688087

29 October 2022

language of work or name

1 reference

1 January 1991

1 reference

full work available at URL

27 November 2017

https://api.elsevier.com/content/article/PII:019205619190127S?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90127-S

https://api.elsevier.com/content/article/PII:019205619190127S?httpAccept=text/plain

29 October 2022

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90127-S

International Journal of Immunopharmacology

29 October 2022

published in

1 reference

27 November 2017

volume

13 Suppl 1

1 reference

27 November 2017

page(s)

69-76

1 reference

Structural requirements of the rIn·rCn complex for Induction of human interferon

27 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90127-S

Clinical, immunological, and virological effects of ampligen, a mismatched double-stranded RNA, in patients with AIDS or AIDS-related complex

29 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90127-S

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

29 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90127-S

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group

29 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90127-S

Cellular response to double-stranded RNA.

29 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90127-S

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

29 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90127-S

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

29 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90127-S

PolyI.polyC12U-mediated inhibition of loss of alloantigen responsiveness viral replication in human CD4+ T cell clones exposed to human immunodeficiency virus in vitro

29 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90127-S

Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6

29 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90127-S

Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6.

29 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90127-S

Antiviral activity of mismatched double-stranded RNA against human immunodeficiency virus in vitro

29 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90127-S

Mismatched dsRNA (ampligen) induces protection against genomic variants of the human immunodeficiency virus type 1 (HIV-1) in a multiplicity of target cells

29 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90127-S

In vitro evaluation of mismatched double-stranded RNA (ampligen) for combination therapy in the treatment of acquired immunodeficiency syndrome

29 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90127-S

Comparative study of various immunomodulators for macrophage and natural killer cell activation and antiviral efficacy against exotic RNA viruses

29 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90127-S

Augmentation of human natural killer cell activity by polyinosinic acid-polycytidylic acid and its nontoxic mismatched analogues

29 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90127-S

29 October 2022

Identifiers

1 reference

27 November 2017

1 reference